
GPAS is already a collaboration of multiple universities and academic institutes. Its scope will grow with new partners and allow easy data sharing between countries and establishments. It will also enable identification of similar strains and hopefully lead to ongoing collaborative research in epidemiology, therapeutics and diagnostics of multiple pathogens starting with SARS-CoV02 and TB.